论文部分内容阅读
Background & Aims:We conducted this multicenter retrospective study to evaluate the efficacy of sorafenib combined with transarterial chemoembolization(TACE)compared to TACE monotherapy in intermediate-stage hepatocellular carcinoma(HCC).